Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.6.0.2
Income Taxes
12 Months Ended
Dec. 31, 2016
Income Tax Disclosure [Abstract]  
Income Taxes

NOTE 8 – INCOME TAXES

 

The components of the provision (benefit) for income taxes, in the consolidated statements of operations are as follows (in thousands):

 

    Year Ended December 31,  
    2016     2015     2014  
Current                        
Federal   $ -     $ -     $ -  
State     -       -       -  
      -       -       -  
Deferred                        
Federal     (936 )     (1,403 )     (2,471 )
State     (66 )     (73 )     (74 )
      (1,002 )     (1,476 )     (2,545 )
Total   $ (1,002 )   $ (1,476 )   $ (2,545 )
                         
Income taxes from continuing operations before valuation allowance   $ (1,002 )   $ (1,476 )   $ (2,545 )
Change in valuation allowance     1,002       1,476       2,545  
Income tax (benefit)     -       -       -  
Total   $ -     $ -     $ -  

 

A reconciliation of the statutory federal income tax expense (benefit) to the effective tax is as follows (in thousands):

 

    Year Ended December 31,  
    2016     2015     2014  
                   
Statutory rate - federal   $ (975 )   $ (1,224 )   $ (2,662 )
State taxes, net of federal benefit     (41 )     (305 )     (51 )
Permanent differences and other     14       53       168  
Income tax from continuing operation before valuation allowance     (1,002 )     (1,476 )     (2,545 )
                         
Change in valuation allowance     1,002       1,476       2,545  
                         
Income tax (benefit)     -       -       -  
Total   $ -     $ -     $ -  

 

The components of permanent and other differences are as follows (in thousands):

 

    Year Ended December 31,  
    2016     2015     2014  
Permanent items:                        
Meals and Entertainment   $ 14     $ 7     $ 7  
Return to provision adjustment     -       -       -  
Charitable contributions     -       -       1  
Share-based compensation expense for stock options granted     -       46       160  
    $ 14     $ 53     $ 168  

 

The tax effects of the primary “temporary differences” between values recorded for assets and liabilities for financial reporting purposes and values utilized for measurement in accordance with tax laws giving rise to our deferred tax assets are as follows (in thousands):

 

    Year Ended December 31,  
    2016     2015     2014  
                   
Net operating loss and capital loss carryforward   $ 18,019     $ 16,921     $ 14,983  
Consulting-royalty costs     -       (8 )     39  
Trademark     576       671       752  
Investment in Phusion     938       1,103       (483 )
Depreciation     (304 )     (103 )     (45 )
Other     1,159       802       2,508  
Valuation allowance     (20,388 )     (19,386 )     (17,754 )
Total   $ -     $ -     $ -  

 

A valuation allowance for all of our net deferred tax assets has been provided as we are unable to determine, at this time, that the generation of future taxable income against which the net operating loss (“NOL”) carryforwards could be used can be predicted to be more likely than not. The net change in the valuation allowance for Fiscal 2016, 2015 and 2014 was $1.0 million, $1.6 million and $2.7 million, respectively. Certain exercises of options and warrants, and restricted stock issued for services that became unrestricted resulted in reductions to taxes currently payable and a corresponding increase to additional-paid-in-capital for prior years. In addition, certain tax benefits for option and warrant exercises totaling $6.5 million are deferred and will be credited to additional-paid-in-capital, and not income tax expense, if the NOL’s attributable to these exercises are utilized. The net operating loss carry-forwards currently approximate $47.1 million for federal purposes will expire beginning in Fiscal 2020 through 2036. Additionally, there are net operating loss carry-forwards of $22.1 million for state purposes that will expire beginning in Fiscal 2020 through 2036.